Form D · Investing
Knopp Sub Investments II LLC
Pittsburgh, PA · CIK 0002044008
Offering snapshot reported Aug 6, 2025 · SEC filing
- Reported sold
- $10.1M Offering amount: $10.1M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $25.3K Reported outside-investor minimum
- First sale
- Jul 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 6, 2025 | Initial | $10,100,000 | No comparison | 23 | SEC filing |
| May 30, 2025 | Initial | $4,604,541 | No comparison | 16 | SEC filing |
| Dec 2, 2024 | Amendment | $10,100,000 | $8,339,570vs Nov 20, 2024 | 33 | SEC filing |
| Nov 20, 2024 | Initial | $1,760,430 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553901
Source: Form D, filed Aug 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Knopp Biosciences Llc | Director, Promoter |
| Frank J. Lucchino Jr. | Director, Executive |
| Knopp Biosciences Llc N/A | Director, Promoter |
| Charles F. O'hanlon Iii | Director, Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
2403 Sidney Street Suite 206
Pittsburgh, PA, 15203
Pittsburgh, PA, 15203